Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations.

The second dose of Oxford-AstraZeneca COVID-19 vaccine will be administered from Wednesday (April 28), says State Minister of Production, Supply, and Regulation of Pharmaceuticals Prof. Channa ...

While Ideaya is letting Amgen go, it is retaining an interest in MAT2A-PRMT5 combinations. Ideaya has a PRMT5 inhibitor, ...

AstraZeneca's lengthy and turbulent development ... The CTLA4 inhibitor – now given the brand name Imjudo – is only the second drug in the class to be approved after Bristol-Myers Squibb's ...

The EU is the second market for the drug after the US, where it was approved under the Attruby brand name last November, on ...

Use of DOACs in patients with ICH and AF resulted in a remarkable reduction in ischemic stroke, but that benefit was partially offset by an increase in ICH recurrence.

Amgen, Inc. ( NASDAQ: AMGN) Oppenheimer 35th Annual Healthcare Life Sciences Conference Call February 12, 2025 11:20 AM ET Narimon Honarpour - Senior Vice President, Global Development Justin Claeys - ...

The second scenario consisted of cases in which people received a booster dose of CoronaVac as well ... there are also the viral vector vaccines (AstraZeneca and Janssen), in which another ...

Investors with a lot of money to spend have taken a bullish stance on AstraZeneca AZN. And retail traders should know. We noticed this today when the positions showed up on publicly available ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Canadiens player will start the competition on the second line of his team, alongside Sebastian Aho and Roope Hintz. Artturi Lehkonen, Aleksander Barkov, and Mikko […] Patrik Laine will represent ...